-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
U.S. Stem Cell, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2010 to 2022.
- U.S. Stem Cell, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was -$567K, a 11.6% increase year-over-year.
- U.S. Stem Cell, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$2.86M, a 13.1% increase year-over-year.
- U.S. Stem Cell, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.86M, a 13.1% increase from 2021.
- U.S. Stem Cell, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.29M, a 13.7% decline from 2020.
- U.S. Stem Cell, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$2.89M, a 24.6% increase from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)